Chesterford Research Park provides the very best flexible and future-proofed environment for both established and early stage technology R&D companies seeking accommodation. Building on 60 years of continuous research and development at Chesterford, our innovative occupiers thrive in state-of-the-art buildings and enjoy modern, central facilities, all set within a unique parkland environment.
Groundbreaking Science
amongst an innovative community
The Park is home to companies that are making a real difference. Scientists, investors and entrepreneurs work side by side at the Park, developing life-changing drugs within a sustainable environment.
Who you'll meet here
News from around The Park
Arecor presents positive data from Phase I Clinical Trial of ultra-concentrated ultra-rapid acting insulin AT278
Arecor Therapeutics today presents positive results from its Phase I clinical trial of the ultra-concentrated, ultra-rapid acting insulin candidate, AT278, in Type 2 diabetics with a high body mass index (BMI).
Read More
Healx announces $47 million Series C financing and FDA clearance of phase 2 IND for Neurofibromatosis type 1 trial
Healx, an AI-enabled, clinical-stage biotech company specialising in rare diseases, announced it has raised $47 million in a Series C round.
Read more
Peter Campbell named CSO at Quotient Therapeutics
Renowned scientist Peter Campbell has become Chief Scientific Officer of Cambridge UK and US somatic genomics company Quotient Therapeutics.
Read More
CellCentric’s $60m raise for Phase III readiness and set-up in US
CellCentric has secured the three invesments which total more than $60m.
Read More
CellCentric Secures $35 Million Investment from RA Capital Management
CellCentric announces that it has secured a $35 million investment from RA Capital Management.
Read More
Sweetness in Seattle: PartitionBio wins Gates Foundation support
PartitionBio has secured $480,500 from the Gates Foundation in Seattle to develop a platform to unlock previously undruggable targets.
Read more
Life@ThePark
The Park is being developed as a 250 acre low density scheme, which means that the natural environment, arboretum and wide-open spaces play a crucial role alongside the cutting-edge research facilities. Not only that, but the purpose-built hub building, The Nucleus, at the heart of the Park provides all the facilities required to make working life simple, enjoyable and rewarding - as well as fostering collaboration between the community as they meet and interact there.
Meeting Space
The Nucleus, the 22,000 sq ft central facilities hub at the Park, is a contemporary conference facility near Cambridge that can cater for anything from a board meeting for 12, to a conference or event for 200 and every permutation in between.
Start-up to Global HQ
Whether you are an established business looking to develop your own bespoke, modern global HQ or a start-up looking for fully-fitted R&D suites, Chesterford Research Park has a range of flexible accommodation and build to suit opportunities for companies of all sizes.
Build to Suit
Bespoke build options at Chesterford offer occupiers flexible, innovative space perfectly suited to their requirements.
Read more
Science Village
The Science Village offers companies flexible, high quality and prestigious self-contained accommodation.
Read More
Mansion House
Enjoy rooms with a view at The Mansion House; a variety of office suites from 342sq ft to 1,672sq ft available on flexible lease terms.
Read More
Location
The location of this site is no accident – this rural, yet convenient setting means you can concentrate on delivering ground breaking research without the distraction and congestion of urban locations.
